CSPG4: a prototype oncoantigen for translational immunotherapy studies

Thanks to striking progress in both the understanding of anti-tumor immune response and the characterization of several tumor associated antigens (TAA), a more rational design and more sophisticated strategies for anti-tumor vaccination have been possible. However, the effectiveness of cancer vaccin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Transl Med
Autors principals: Rolih, Valeria, Barutello, Giuseppina, Iussich, Selina, De Maria, Raffaella, Quaglino, Elena, Buracco, Paolo, Cavallo, Federica, Riccardo, Federica
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5494135/
https://ncbi.nlm.nih.gov/pubmed/28668095
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-017-1250-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars